This issue of Hopkins Medicine magazine brims with stories showcasing the translational research of the brightest minds at Johns Hopkins — from a new “EyePhone” app that promises to dramatically improve the way emergency department physicians diagnose stroke to the development of a pioneering prosthetic hand that can grasp a plastic cup of water with human-like dexterity.

Many of these developments are already making an impact on patient care. In “Window Into the Brain,” for example, you’ll read how advances in eye imaging have significantly improved the diagnosis and management of multiple sclerosis. In other cases, promising breakthroughs are on the cusp of dramatically changing the standard of care for common conditions, from cardiac arrhythmia to Alzheimer’s disease.

In nearly every instance, today’s life-changing treatments were made possible through federal funding and build on years of work from earlier investigators. Case in point: the pioneering studies of hematologists George Dover and Sam Charache whose findings dating back to the 1970’s set the standard for treatment of sickle cell disease, a devastating condition that now — excitingly — can be cured.

This “building on the shoulders of giants,” a hallmark of innovation in academic medicine, is aptly captured in our Annals story, which looks back at 50 years of the Medical Scientist Training Program (MSTP) at Johns Hopkins. Over those five decades, close to 500 talented young clinician-scientists have learned from the greats, then gone on to make their own impressive marks, finding cures and improving treatments in virtually every corner of medicine.

It’s worth noting that the MSTP program, in place at dozens of academic medical centers across the nation, was launched in 1964 through the vision of the National Institutes of Health, which provided full funding for participants to complete both their M.D. and Ph.D. degrees, and subsequently has supported much of their ongoing research.

As I write this, we are living in a season of unprecedented federal funding cuts, with great uncertainty and anxiety about what lies ahead. I hope that this issue of Hopkins Medicine can bear witness to the crucial impact of our clinician-scientists’ work and stand as a testament to this vital truth: Research saves lives.